Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LRRC4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRR9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYH7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB40C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF678 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KANK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996404 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZRN3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on